On 4/17/24, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) stock enjoyed a major increase of 29.4%, closing at $5.24. Moreover, trading volume in this advance was exceptionally high at 916% of normal. Relative to the market the stock has been weak over the last nine months but has risen 20.2% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, VNDA is expected to be Value Creation neutral.
Vanda Pharmaceuticals has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Vanda Pharmaceuticals has a good Appreciation Score of 76 but a poor Power Rating of 18, leading to the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment